alphaveBIOCON₹391.00

Biocon Ltd.

₹ CrorePeersSUNPHARMA DRREDDY SYNGENE MANKIND GLENMARK LAURUSLABS ALKEM LUPINMcap ₹63,381 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	7,418.1	8,708.2	9,472.8	9,472.8
+ Capital Work-in-Progress	3,985.2	4,101.7	4,612.7	4,612.7
+ Goodwill	16,372.4	16,785.7	18,377.5	18,377.5
+ Other Intangibles	6,853.1	6,469.4	8,635.6	8,635.6
+ Intangibles under Development	4,008.1	4,406.7	2,374.0	2,374.0
+ Non-current Investments	684.1	679.7	1,089.3	1,089.3
+ Other Non-current Financial Assets	412.3	255.7	638.9	638.9
Non-current Financial Assets	1,096.4	935.4	1,728.2	1,728.2
+ Deferred Tax Assets	317.3	257.7	555.6	555.6
+ Other Non-current Assets	840.9	846.3	714.4	714.4
Total Non-current Assets	40,891.5	42,511.1	46,470.8	46,470.8
Current Assets
+ Inventories	4,943.9	4,931.1	6,085.7	6,085.7
+ Current Investments	315.6	447.3	689.8	689.8
+ Trade Receivables	6,230.6	5,487.9	5,986.8	5,986.8
+ Cash & Cash Equivalents	1,233.6	3,227.1	2,416.5	2,416.5
+ Other Bank Balances	1,025.1	893.1	777.1	777.1
+ Other Current Financial Assets	715.3	552.3	336.8	336.8
Current Financial Assets	9,520.2	10,607.7	10,207.0	10,207.0
+ Other Current Assets	715.1	0.0	887.1	887.1
Total Current Assets	15,179.2	16,286.2	17,179.8	17,179.8
Total Assets	56,070.7	58,797.3	63,650.6	63,650.6
Equity
+ Equity Share Capital	600.3	600.3	810.5	810.5
+ Other Equity / Reserves	19,183.4	21,043.7	33,221.3	33,221.3
Equity — Owners of Parent	19,783.7	21,644.0	34,031.8	34,031.8
+ Minority Interest	5,491.1	6,068.5	2,589.7	2,589.7
Total Equity	25,274.8	27,712.5	36,621.5	36,621.5
Liabilities
+ Borrowings — Non-current	12,932.4	12,405.4	10,746.3	10,746.3
+ Other Non-current Financial Liab	1,564.9	3,390.5	1,160.3	1,160.3
Non-current Financial Liabilities	14,497.3	15,795.9	11,906.6	11,906.6
+ Provisions — Non-current	237.6	260.8	330.3	330.3
+ Deferred Tax Liabilities	391.5	357.7	241.7	241.7
+ Other Non-current Liabilities	310.7	336.6	481.3	481.3
Non-current Liabilities	15,437.1	16,751.0	12,959.9	12,959.9
+ Borrowings — Current	2,797.2	5,350.1	4,078.4	4,078.4
+ Trade Payables	6,272.0	6,548.7	6,772.1	6,772.1
+ Other Current Financial Liab	5,056.4	1,045.5	1,286.9	1,286.9
Current Financial Liabilities	14,125.6	12,944.3	12,137.4	12,137.4
+ Provisions — Current	179.5	191.6	255.5	255.5
+ Current Tax Liabilities	276.9	173.1	416.0	416.0
+ Other Current Liabilities	776.8	1,024.8	1,260.3	1,260.3
Current Liabilities	15,358.8	14,333.8	14,069.2	14,069.2
Total Liabilities	30,795.9	31,084.8	27,029.1	27,029.1
Total Equity & Liabilities	56,070.7	58,797.3	63,650.6	63,650.6
Assets — additional as-filed lines
+ Current Tax Assets	0.0	747.4	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	131.5	135.1	135.1
+ Dues to Other Creditors — Current	—	6,417.2	6,637.0	6,637.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.